IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, very early in the IFN-era in CML, immune studies unraveled IFN-alpha to have very potent immune enhancing capacity, inducing recognition and elimination of CML cells by the immune system [11, 12].